Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
Publishes | Weekly | Episodes | 20 | Founded | 7 years ago |
---|---|---|---|---|---|
Categories | MedicineScienceHealth & Fitness |
The FDA has made strides in improving transparency and data access, and has implemented tools to allow the pharmaceutical industry and the public to transform raw data into usable information. One of these tools is called the FDA Adverse Event Report... more
The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body’s infection-fighting immune system. This can c... more
Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the recent approval of bevacizumab-awwb, a biosimilar to US-licensed Avastin, marketed as MVASI. MVASI is the first biosimilar approved in the US fo... more
The FDA announced that it is requiring a new class warning and other safety measures for all gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (or MRI) concerning gadolinium remaining in patients’ bodies, including the brain, fo... more
The FDA announced that a review of four large clinical safety trials shows that treating asthma with long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS) does not result in significantly more serious asthma-related side... more
Guest: Leonard H. Calabrese, DO more
Many listeners may be familiar with the FDA's Adverse Event Reporting System or FAERS. Data in FAERS supports the FDA's post-marketing safety surveillance program for drug products and therapeutic biologic products. Recently, CDER's Office of Surveil... more
FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease. more
Find out how many people listen to FDA Drug Information Updates and see how many downloads it gets.
We scanned the web and collated all of the information that we could find in our comprehensive podcast database.
Listen to the audio and view podcast download numbers, contact information, listener demographics and more to help you make better decisions about which podcasts to sponsor or be a guest on.
Listeners, engagement and demographics and more for this podcast.
Gender Skew | Engagement Score | Primary Location | |||
---|---|---|---|---|---|
Social Media Reach |
Rephonic provides a wide range of data for three million podcasts so you can understand how popular each one is. See how many people listen to FDA Drug Information Updates and access YouTube viewership numbers, download stats, chart rankings, ratings and more.
Simply upgrade your account and use these figures to decide if the show is worth pitching as a guest or sponsor.
There are two ways to find viewership numbers for podcasts on YouTube. First, you can search for the show on the channel and if it has an account, scroll through the videos to see how many views it gets per episode.
Rephonic also pulls the total number of views for each podcast we find a YouTube account for. You can access these figures by upgrading your account and looking at a show's social media section.
Podcast streaming numbers or 'plays' are notoriously tricky to find. Fortunately, Rephonic provides estimated listener figures for FDA Drug Information Updates and three million other podcasts in our database.
To check these stats and get a feel for the show's audience size, you'll need to upgrade your account.
To see how many followers or subscribers FDA Drug Information Updates has, simply upgrade your account. You'll find a whole host of extra information to help you decide whether appearing as a sponsor or guest on this podcast is right for you or your business.
If it's not, use the search tool to find other podcasts with subscriber numbers that match what you're looking for.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. You can see some of this data for free. But you will need to upgrade your account to access premium data.
FDA Drug Information Updates launched 7 years ago and published 20 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contact information for you.
Our systems scan a variety of public sources including the podcast's official website, RSS feed, and email databases to provide you with a trustworthy source of podcast contact information. We also have our own research team on-hand to manually find email addresses if you can't find exactly what you're looking for.
Rephonic pulls reviews for FDA Drug Information Updates from multiple sources, including Apple Podcasts, Castbox, Podcast Addict and more.
View all the reviews in one place instead of visiting each platform individually and use this information to decide whether this podcast is worth pitching as a guest or sponsor.
You can view podcasts similar to FDA Drug Information Updates by exploring Rephonic's 3D interactive graph. This tool uses the data displayed on the 'Listeners Also Subscribed To' section of Apple Podcasts to visualise connections between shows.